Concepedia

Stephanie Chang

SC

Statistics

Publications

13

Citations

984

H-Index

12

Active since

2010

Affiliations

Revolution Medicines (United States)(Current)

Harvard University

Brigham and Women's Hospital

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

Stephanie Chang is an author at Revolution Medicines (United States) specializing in cell biology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2010–2025

13

Publications

13

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 268 citations · Full text

Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

Jingjing Jiang, Lingyan Jiang, Benjamin J. Maldonato et al. · Cancer Discovery · 2024 · 231 citations · Full text

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 150 citations · Full text

Guidance of Cell Migration by Substrate Dimension

Stephanie Chang, Wei-hui Guo, Youngeun Kim et al. · Biophysical Journal · 2013 · 94 citations · Full text

, , +4

Reprogramming Directional Cell Motility by Tuning Micropattern Features and Cellular Signals

Keiichiro Kushiro, Stephanie Chang, Anand R. Asthagiri · Advanced Materials · 2010 · 48 citations

1–5 of 13